Monte Rosa Therapeutics Inc. (NASDAQ: GLUE)
$4.65
-0.2200 ( -4.52% ) 65.9K
Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutically-relevant proteins. Utilizing the QuEEN platform, the company employ artificial intelligence and proprietary experimental tools to identify target proteins for degradation by MGDs. With a diverse library of over 50,000 MGD molecules, their most advanced product candidate, MRT-2359, targets the translation termination factor protein GSPT1 for potential use in MYC-driven tumors. The company's focus lies in advancing its pipeline of MGDs, aiming to provide novel therapeutic modalities for various diseases.
Market Data
Open
$4.65
Previous close
$4.87
Volume
65.9K
Market cap
$286.92M
Day range
$4.64 - $5.08
52 week range
$2.44 - $8.84
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 09, 2024 |
8-k | 8K-related | 13 | Jun 27, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
4 | Insider transactions | 2 | Jun 13, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
4 | Insider transactions | 1 | Jun 13, 2024 |
8-k | 8K-related | 11 | Jun 12, 2024 |
3 | Insider transactions | 2 | Jun 05, 2024 |